Crypto · News reference
Why Is Apimeds Pharmaceuticals Stock Gaining Monday?
Apimeds stock (APUS) jumped over 43% following a 2-year insurance blockchain deal between subsidiary MindWave and BlockAssure.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Apimeds Pharmaceuticals shares are trading higher after the company announced its subsidiary, MindWave Innovations, signed a 2-year master maintenance and service agreement with BlockAssure.
Apimeds' MindWave Announces 2-Year Contract To Build, Run Insurance Blockchain For BlockAssure, With 20% Of Planned Token Supply; Fees Not Disclosed